- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Korsana Biosciences, Inc (KRSA)
Korsana Biosciences, Inc stock price live, this page displays NASDAQ KRSA stock exchange data. View the KRSA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Korsana Biosciences, Inc real time stock price chart below.
What Is the Korsana Biosciences, Inc Stock Price Today?
The Korsana Biosciences, Inc stock price today is 31.905.
What Is the Stock Symbol for Korsana Biosciences, Inc?
The stock symbol for Korsana Biosciences, Inc is "KRSA."
What Stock Exchange Does Korsana Biosciences, Inc Trade On?
Korsana Biosciences, Inc is listed and trades on the NASDAQ stock exchange.
Is Korsana Biosciences, Inc a Good Stock to Buy?
Determining whether Korsana Biosciences, Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KRSA quote. (ISIN: US23255M3034)
What Is the Korsana Biosciences, Inc Stock Price Today?
The Korsana Biosciences, Inc stock price today is 31.905.
What Is the Stock Symbol for Korsana Biosciences, Inc?
The stock symbol for Korsana Biosciences, Inc is "KRSA."
What Stock Exchange Does Korsana Biosciences, Inc Trade On?
Korsana Biosciences, Inc is listed and trades on the NASDAQ stock exchange.
Is Korsana Biosciences, Inc a Good Stock to Buy?
Determining whether Korsana Biosciences, Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KRSA quote. (ISIN: US23255M3034)
Fair Value
An estimate of a Korsana's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
25.220
32.120
52 wk Range
1.380
59.360
Unusual trading volume
1/2
Fair Value
An estimate of a Korsana's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
25.22032.120
52 wk Range
1.38059.360
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
KRSA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Korsana's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
55.000
Upside
+72.39%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Form 13D/A CYCLERION THERAPEUTICS For: 21 July- Investing.com
Form 13G CYCLERION THERAPEUTICS INC For: 7 May- Investing.com
- Form 13D/A CYCLERION THERAPEUTICS For: 21 July
- Investing.com
- Form 13G CYCLERION THERAPEUTICS INC For: 7 May
- Investing.com
Cyclerion to merge with Korsana in $380 million deal- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 55.000
(+72.39% Upside)
Earnings
Latest Release
Aug 04, 2026
EPS / Forecast
-0.41 / --
Revenue / Forecast
-- / --
Compare KRSA to Peers and Sector
Metrics to compare | KRSA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKRSAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.2x | −2.3x | −0.3x | |
PEG Ratio | 0.02 | −0.05 | 0.00 | |
Price/Book | 2.9x | 3.5x | 2.6x | |
Price / LTM Sales | 7.9x | 4.6x | 3.0x | |
Upside (Analyst Target) | 138.1% | 244.7% | 54.6% | |
Fair Value Upside | Unlock | 5.8% | 8.6% | Unlock |
Korsana Biosciences, Inc. develops therapeutic antibodies for the treatment of neurodegenerative diseases. The company has developed Therapeutic Targeting (THETA), a blood-brain barrier-penetrant shuttle platform designed to enhance central nervous system exposure of investigational therapies and enable delivery of large therapeutic molecules across the blood-brain barrier into the central nervous system. The company advances a pipeline of THETA-enabled therapeutics with an initial focus on neurodegenerative disorders. Its lead product candidate is KRSA-028, an anti-amyloid beta antibody for the treatment of Alzheimer's disease, which combines the THETA platform with elements of anti-amyloid beta approaches and targets a clinically relevant form of amyloid beta designed to improve brain uptake while reducing effects on reticulocytes. The company is also advancing a pipeline of additional THETA-enabled therapies for other neurodegenerative diseases. Korsana Biosciences, Inc. was incorporated in 2024 and is based in Waltham, Massachusetts.
People Also Watch
FAQ
What Is the Korsana (KRSA) Stock Price Today?
The Korsana stock price today is 31.905 USD.
What Stock Exchange Does Korsana Trade On?
Korsana is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Korsana?
The stock symbol for Korsana is "KRSA."
What Is the Korsana (KRSA) Afterhours Price Today? (Afterhours variable test: 31.190) Current Date: Sep 12, 2026
After hours price: 31.190. After hours price change (units): -0.715. Price change percentage: -2.240%
What Is the Korsana Market Cap?
As of today, Korsana market cap is 16.420M USD.
From a Technical Analysis Perspective, Is KRSA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Korsana Stock Split?
Korsana has split 2 times.
What is the current trading status of Korsana (KRSA)?
As of Sep 12, 2026, Korsana (KRSA) is trading at a price of 31.905 USD, with a previous close of 24.560 USD. The stock has fluctuated within a day range of 25.220 USD to 32.120 USD, while its 52-week range spans from 1.380 USD to 59.360 USD.
What Is Korsana (KRSA) Price Target According to Analysts?
The average 12-month price target for Korsana is 55.000 USD, with a high estimate of 55 USD and a low estimate of 55 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +72.39% Upside potential.
What Is the KRSA Premarket Price?
KRSA's last pre-market stock price is 24.000 USD. The pre-market share volume is 90.000, and the stock has decreased by -0.560, or -2.280%.
What Is the KRSA After Hours Price?
KRSA's last after hours stock price is 31.190 USD, the stock has decreased by -0.715, or -2.240%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.